Cardiology Division, Meir Medical Center, Kfar Saba, Israel.
J Interv Cardiol. 2010 Aug;23(4):377-81. doi: 10.1111/j.1540-8183.2010.00550.x. Epub 2010 Jul 6.
To evaluate the Prokinetic bare metal stent implanted in patients presenting with acute coronary syndrome (ACS).
We retrospectively studied ACS patients who underwent percutaneous coronary intervention (PCI) with a Prokinetic stent implantation. Excluded were patients presenting with cardiogenic shock, undergoing PCI to left main coronary artery (LM), or having implantation of additional stents other than Prokinetic. Six and 12 months clinical follow-up was obtained by phone.
A total of 140 Prokinetic stents were implanted in 117 patients (age 64+/-13.0 years, 78% men). Thirty two percent of the patients had unstable angina, 36% had non ST-elevation myocardial infarction (NSTEMI) and 33% had ST-elevation myocardial infarction (STEMI). Forty two percent of lesions were categorized as B2 and 21% as C type. Procedural success was achieved in 99.1% of lesions. Clinical success was achieved in 97.4% of patients. Major adverse cardiac events (MACE) rate was 8.5% and 11.1% at 6 and 12 months follow-up, respectively. The incidence of cardiac death, MI and TLR was 2.6%, 3.4% and 2.6%, respectively at 6 months, and 4.3%, 4.3%, 2.6% respectively at 12 months.
Clinical outcomes at 6 and 12 months after Prokinetic stent implantation are excellent and may be attributable to its unique combination of composition, design and coating.
评估 Prokinetic 裸金属支架在急性冠状动脉综合征（ACS）患者中的应用。
我们回顾性研究了接受 Prokinetic 支架置入的经皮冠状动脉介入治疗（PCI）的 ACS 患者。排除了因心源性休克、左主干冠状动脉（LM）PCI 或植入除 Prokinetic 以外的其他支架而就诊的患者。通过电话获得了 6 个月和 12 个月的临床随访。
共对 117 例患者（年龄 64+/-13.0 岁，78%为男性）的 140 个 Prokinetic 支架进行了植入。32%的患者为不稳定型心绞痛，36%为非 ST 段抬高型心肌梗死（NSTEMI），33%为 ST 段抬高型心肌梗死（STEMI）。42%的病变为 B2 型，21%为 C 型。99.1%的病变达到了手术成功。97.4%的患者达到了临床成功。主要不良心脏事件（MACE）发生率为 8.5%和 11.1%，分别在 6 个月和 12 个月随访时。心脏性死亡、心肌梗死和 TLR 的发生率分别为 2.6%、3.4%和 2.6%，分别在 6 个月时，4.3%、4.3%和 2.6%，分别在 12 个月时。
Prokinetic 支架植入后 6 个月和 12 个月的临床结果优异，这可能与其独特的组成、设计和涂层组合有关。
